http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105726657-A
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0ec795b989cd080992372eb9681ea624 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-07 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P27-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-534 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-714 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-855 |
filingDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8e115baf46a62bae5bb579a3bfd16c2d |
publicationDate | 2016-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-105726657-A |
titleOfInvention | Traditional Chinese medicine eye drops for treating ocular inflammation and manufacturing method of eye drops |
abstract | The invention belongs to the field of medicine, and relates to traditional Chinese medicine eye drops for treating ocular inflammation and a manufacturing method of the eye drops, specifically to traditional Chinese medicine eye drops for treating ophthalmic diseases, such as viral keratitis, viral conjunctivitis, and acute or chronic conjunctivitis, and a manufacturing method of the eye drops. The eye drops comprise the following medicine components, by weight part, 10-30 parts of isatis roots, 10-50 parts of folium isatidis, 5-10 parts of white chrysanthemum flowers, 2-3 parts of borneol, 5-8 parts of honeysuckle flowers, 3-5 parts of pearl powder, 3-5 parts of mint, 10-15 parts of hebra senecionis scandentis, 0.1-1 part of vitamin A, and 0.1-1 part of vitamin B12. The adopted medicines conform to regulations of Pharmacopoeia of the People's Republic of China, and are safe and reliable. The medicines match each other and have the efficacy of resisting inflammation and allergy, and nourishing trigeminal nerves at corneal endings. The eye drops have characteristics of an accurate and quick curative effect, and high cure rate, and are free of side effects. |
priorityDate | 2014-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 174.